Benjamin Graham fit · Defensive deep-value investing
Is Corcept Therapeutics Inc. (CORT) a Benjamin Graham Stock?
Meets 3/7 Graham criteria — partially qualifies.
55/100
CMixed signals
3/7 criteria passed
Benjamin Graham's Criteria, Applied to CORT
P/E ≤ 15
key—
P/B ≤ 1.5
key14.2x
Current ratio ≥ 2
3.1x
Debt / Equity ≤ 1
0.0x
How CORT Scores on Other Strategies
Live Financial Snapshot
Market cap
$4.34B
P/E (TTM)
26.2x
ROIC (TTM)
17.09%
Gross margin
98.19%
Frequently Asked Questions
What is CORT's Benjamin Graham fit score?
CORT scores 55/100 on our Benjamin Graham fit engine — grade C. Meets 3/7 Graham criteria — partially qualifies.
Does Benjamin Graham actually own CORT?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends CORT.
How often is this score updated?
CORT's Benjamin Graham fit score is recomputed daily from the latest TTM financials.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Benjamin Graham personally owns or recommends CORT.